⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
globenewswire.com
AARD
Portnoy Law Firm Announces Class Action on Behalf of Aardvark Therapeutics, Inc. Investors
globenewswire.com
AARD
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
prnewswire.com
AARD
AARD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AARD
Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit
businesswire.com
AARD
Investors Urged to Contact Levi & Korsinsky for Information Before October 13, 2026 - Aardvark Therapeutics, Inc. (AARD)
accessnewswire.com
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AARD
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
globenewswire.com
AARD
Pomerantz LLP Announces Commencement of Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD